Skip to main content
Clinical Trials/ACTRN12622000012774
ACTRN12622000012774
Recruiting
未知

Multi-centre prospective observational cohort study investigating association between anti-neutrophil cytoplasmic antibodies (ANCA) results and relapse of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis

Dr Dwarakanathan Ranganathan0 sites109 target enrollmentJanuary 11, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
ANCA Vasculitis
Sponsor
Dr Dwarakanathan Ranganathan
Enrollment
109
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr Dwarakanathan Ranganathan

Eligibility Criteria

Inclusion Criteria

  • Patients with ANCA vasculitis based on compatible serology, radiology, histology and/or biochemistry.
  • Participants need to have been enrolled into the Queensland Renal Biopsy Registry

Exclusion Criteria

  • ANCA negative vasculitis

Outcomes

Primary Outcomes

Not specified

Similar Trials